About
Doctor of Pharmacy. 503B compounding specialist. Published in JACCP.
Threads by SarahChen_PharmD
PSA: Verify your compounding pharmacy accreditation (PCAB/ACHC)in Public Square
GLP-1 for type 1 diabetes as adjunct — need advicein Public Square
Semaglutide pharmacokinetics — half-life, Tmax, steady state modelingin Semaglutide (Ozempic / Wegovy)
Reconstitution and storage guide — evidence-based best practicesin Semaglutide (Ozempic / Wegovy)
Drug interactions with semaglutide — gastric emptying effectsin Semaglutide (Ozempic / Wegovy)
Drug interactions with semaglutide — 12 month updatein Semaglutide (Ozempic / Wegovy)
Switching from semaglutide to tirzepatide — transition protocolin Tirzepatide (Mounjaro / Zepbound)
Retatrutide Phase 2 dose-response analysis — need advicein Retatrutide & Triple Agonists
503A vs 503B compounding — regulatory framework explainedin Compounding & Formulation
Bacteriostatic water sourcing and sterility considerationsin Compounding & Formulation
Oral vs injectable GLP-1: bioavailability and efficacy comparisonin Oral GLP-1 Agonists
Orforglipron food interaction profile — no fasting requirementin Oral GLP-1 Agonists
Orforglipron and hepatic first-pass metabolismin Oral GLP-1 Agonists
Has anyone dealt with cost comparison: oral vs injectable semaglutide?in Oral GLP-1 Agonists